Efficiency of cytology samples for pd-l1 evaluation and comparison with tissue samples | Zendy

İbrahim Kulaç | Zendy; Asli Aydin | Zendy; Pınar Bulutay | Zendy; Pınar Fırat | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficiency of cytology samples for pd-l1 evaluation and comparison with tissue samples

Author(s) -

İbrahim Kulaç,

Asli Aydin,

Pınar Bulutay,

Pınar Fırat

Publication year - 2020

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2020.01494

Subject(s) - medicine , cytology , lung cancer , biopsy , cancer , pd l1 , pathology , immunohistochemistry , significant difference , oncology , immunotherapy

Lung cancer is the leading cause of cancer-related death. PD-L1 blockers have become a first-line option for advanced non-small cell lung cancer (NSCLC) patients. Guidelines require the assessment of PD-L1 expression by immunohistochemistry. Although tissue samples are widely used, cytologic samples could be an alternative. In this study, we compared cytologic samples with tissue samples for PD-L1 evaluation in NSCLC cases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research